The Swedish national guidelines on prostate cancer, part 1: early detection, diagnostics, staging, patient support and primary management of non-metastatic disease
Source : https://www.tandfonline.com/doi/full/10.1080/21681805.2022.2094462
Abstract There is now an unprecedented amount of evidence to consider when revising prostate cancer guidelines. We believe that there is a value in publishing summaries of national clinical guidelines...
Conclusions: The 2022 Swedish prostate cancer guidelines include several new recommendations and some that differ from the European guidelines.
Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal Balloons - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35774493/
doi: 10.14338/IJPT-21-00039. 1 Department of Radiation Medicine, Georgetown University Hospital, Washington, DC, USA. 2 Department of Urology, Georgetown University Hospital, Washington, DC, USA. 3 Department of Radiology, Georgetown University Hospital,...
Conclusion: Early clinical outcomes of patients treated with PBS–PBT using Monte Carlo–based planning, fiducial placement, and rectal spacers sans endorectal balloons demonstrate minimal treatment-related toxicity with good oncologic outcomes. Rectal spacer stabilization without the use of endorectal balloons is feasible for the use of...
-
Prostate Cancer Connect4yrKey Points • Source: International Journal of Particle Therapy • Relevance: “Early clinical outcomes of patients treated with PBS–PBT using Monte Carlo–based planning, fiducial placement, and rectal spacers sans endorectal balloons demonstrate minimal treatment-related Show More
Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting Therapies
Source : https://ascopubs.org/doi/10.1200/PO.22.00195
PURPOSE To study the impact of standard-of-care hormonal therapies on metastatic prostate cancer (mPC) clinical genomic profiles in real-world practice, with a focus on homologous recombination-repair (HRR) genes. PATIENTS AND...
Conclusion: Prevalence of HRR-gene aberrations remains stable along mPC progression, supporting the use of diagnostic biopsies to guide poly (ADP-ribose) polymerase inhibitor treatment in metastatic castration-resistant prostate cancer. gLOH scores increase with emerging resistance to hormonal therapies, independently of individual HRR gene...
Editorial Comment on Ischemic proctitis after low-dose-rate brachytherapy using hydrogel spacer for prostate cancer - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35795116/
Nobumichi Tanaka is affiliated with an endowed chair funded by Nihon Medi‐Physics Co. Mariados N, Sylvester J, Shah D et al. Hydrogel spacer prospective multicenter randomized controlled pivotal trial: dosimetric...
Conclusion: Gathering and analyzing information concerning clinical experiences of hydrogel spacer can make a suitable indication and contra-indication criteria. Also, this effort must be necessary to achieve a safety use of hydrogel spacer and avoid severe adverse events in future.
Ischemic proctitis after low-dose-rate brachytherapy using hydrogel spacer for prostate cancer - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35795104/
1 Departments of Integrative Cancer Therapy and Urology Kanazawa University Graduate School of Medical Science Kanazawa Ishikawa Japan. 2 Departments of Radiology Kanazawa University Graduate School of Medical Science Kanazawa...
Conclusions: Herein, we report the first case of ischemic proctitis after low-dose-rate brachytherapy using hydrogel spacer for prostate cancer.